Navigation Links
Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention

BEVERLY, Mass.--(BUSINESS WIRE)--Mar 27, 2007 - Inotek Pharmaceuticals Corporation announced today the presentation of positive Phase 2 clinical data demonstrating the safety of INO-1001 as well as the potential for INO-1001 as a preventative agent for cardiac reperfusion injury. The study was conducted in subjects with acute ST-elevated myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention. The presentation was made in a poster session at the American College of Cardiology (ACC) 56th Annual Scientific Session in New Orleans, Louisiana. INO-1001 is an inhibitor of poly(ADP-Ribose) polymerase (PARP), a nuclear enzyme that directs the repair of damaged DNA via the activation and recruitment of DNA repair enzymes and is being studied as a treatment for certain acute cardiovascular conditions and cancer. Additionally, PARP inhibition shows promise in inflammatory disorders. PARP's role in the inflammatory response may result from its ability to potentiate the activity of key inflammatory transcription factors (NF-kappaB and AP-1).

"Whereas advances in pharmacologic and mechanical reperfusion therapy have improved the outcomes of patients with STEMI, reperfusion injury, which is associated with severe damage to the cardiac tissue, is a significant complication that has no current safe and effective treatment options," commented Dr. Andrew Salzman, Inotek's President and CEO. "These Phase 2 data provide further support for our PARP inhibitor program in cardiovascular disease. These results combined with existing preclinical data suggest that INO-1001 produces significant PARP inhibition and has the potential to protect cardiac tissue from damage."

Researchers from the Brigham and Women's TIMI Study Group and Inotek Pharmaceuticals reported that plasma from patients treated with INO-1001 suppressed ex vivo PARP activation. This effect was observed up to 24 hours following drug admi
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Inotek Pharmaceuticals Announces Publication of Animal Data from Study of PARP Inhibition as Potential Preventative of Brain Injury Following Stroke
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:3/27/2015)... Concord Medical Services Holdings Limited ("Concord ... a leading specialty hospital management solution provider and ... diagnostic imaging centers in China ... agreement under which Concord Medical Services (International) Pte ... agreed to acquire the Fortis Surgical Hospital from ...
(Date:3/26/2015)... 2015 "Whether it,s our family, our friends, ... In a single sentence, Dr. Anthony Coyle ... Pfizer,s Centers for Therapeutic Innovation (CTI), sums ... at America,s biopharmaceutical companies. CTI,s unique ... patient foundations and the National Institutes of Health (NIH) ...
(Date:3/26/2015)... NEW YORK , March 26, 2015 /PRNewswire-USNewswire/ ... on the average American consumer. However, a new ... treating various ailments from the common cold to ... The research, conducted by the Private ... focused on over-the-counter healthcare products, including those essential ...
Breaking Medicine Technology:Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2Consumers can keep over-the-counter medicine affordable by using store brands 2
... 11, 2007 - Neose Technologies,Inc. (Nasdaq ... presentations,were presented with its collaborative partner, ... Factor VIIa at the XXIst,Congress of ... Haemostasis,in Geneva, Switzerland. The data presented ...
... 2007 /PRNewswire-FirstCall/ -- On Wednesday,July 11, 2007, ... European Time members of Cell Therapeutics, Inc.'s ... to discuss today's,announcement of the interim results ... to CPOP-R, in which pixantrone is substituted ...
Cached Medicine Technology:Neose Announces Presentation of Positive Preclinical Data on,GlycoPEGylated Factor VIIa at the XXI Congress of the International,Society on Thrombosis and Haemostasis 2Cell Therapeutics, Inc. Management to Discuss Today's Announcement,of Interim Pixantrone Study Results 2
(Date:3/27/2015)... Trail mix is the perfect, healthy snack for ... and during the game! It’s portable, lightweight and provides a ... introduce a new line of specialty trail mixes that satisfy ... selections packed with nutritious, 100% all natural ingredients. , These ... add protein and fiber to your diet and boost energy. ...
(Date:3/27/2015)... Since September 2014, the country singer has been ... having been in retirement for a period of 13 years. ... return to touring, and concert events have been booking quickly ... sell out for the two shows recently scheduled for May ... the inventory of discounted Garth Brooks tickets for sale. , ...
(Date:3/27/2015)... April 2015 is the 150th anniversary of the ... America’s bloodiest war and the amazing President that led our ... to the Civil War and Abraham Lincoln. This moving event ... the Jane Pickens Theater in Newport, RI. , Chief ... as the master of ceremonies. Dr. Fred Zilian, educator, writer ...
(Date:3/27/2015)... 2015 In light of two lawsuits ... U.S. District Court, District of Massachusetts; and case number ... of Pennsylvania), the San Diego personal injury lawyers of ... announcing that they are available to investigate potential ... were prescribed Zofran while pregnant and who gave birth ...
(Date:3/26/2015)... Alamitos, Calif. (PRWEB) March 26, 2015 ... the grocery store. Fresh produce are today’s traffic magnets. ... a particular supermarket because of their produce department, according ... important than ever as people are looking to add ... National Love Your Produce Manager® Day is April 2. ...
Breaking Medicine News(10 mins):Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 3Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 4Health News:The Law Office of Melinda J. Helbock, A.P.C. Announces That It Is Now Accepting Case Reviews for Potential Zofran Birth Defect Lawsuits 2
... By Steven Reinberg HealthDay Reporter , ... Avastin, when used in combination with standard chemotherapy, is ... one of the most common lung cancers, researchers report. ... might have serious adverse side effects, including life-threatening bleeding, ...
... identified a genetic marker that can help predict the risk of ... of cancer. Reporting online in the July 20 edition of ... variant of the KRAS oncogene was present in 25 percent of ... 61 percent of ovarian cancer patients with a family history of ...
... listeners to you-name-the-sounds from invisible MP3 players -- whether ... Gaga -- only hint at music,s effect on the ... review by Northwestern University researchers that will be published ... together converging research from the scientific literature linking musical ...
... Baker, a J.D./M.S.W. dual degree student in the Law Center ... of Houston, has been named Social Work Student of the ... (NASW/TX). Baker will be honored Oct. 9 at the ... The award, established in 1997, honors a graduate or undergraduate ...
... , COLUMBIA, Mo. ... of illicit drug use among all ethnic groups. Although ... protective factors can reduce their risk for substance abuse, ... Recent findings from a University of Missouri study reveal ...
... the International AIDS Conference in Vienna are charging developed ... to the millions of people in need of lifesaving ... reported by WHO, the International Treatment Preparedness Coalition,s (ITPC), ... of the global pullback on AIDS commitment and funding: ...
Cached Medicine News:Health News:Avastin Largely Safe for Patients With Type of Advanced Lung Cancer 2Health News:Avastin Largely Safe for Patients With Type of Advanced Lung Cancer 3Health News:Avastin Largely Safe for Patients With Type of Advanced Lung Cancer 4Health News:Yale scientists discover new genetic marker of ovarian cancer risk 2Health News:Taking music seriously 2Health News:Taking music seriously 3Health News:University of Houston's Meghan Baker named Social Work Student of the Year in Texas 2Health News:Healthy families, religious involvement buffer youth against risk factors related to drug abuse 2Health News:Writing checks that bounce: World continues to backtrack on HIV treatment 2Health News:Writing checks that bounce: World continues to backtrack on HIV treatment 3Health News:Writing checks that bounce: World continues to backtrack on HIV treatment 4Health News:Writing checks that bounce: World continues to backtrack on HIV treatment 5
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: